MedPath

Found 556472 clinical trials

Sort by:

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab sc Injection in Italy

Not yet recruiting

Conditions: Severe Eosinophilic Asthma

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: AstraZeneca

Target Recruit Count: 335

Registration Number: NCT07214753

Locations: 🇮🇹
AZIENDA ULSS 6 EUGANEA_OSPEDALE DI CITTADELLA U.O.C. di Pneumologia, Cittadella, Padova, Italy
🇮🇹
PRESIDIO OSPEDALIERO SANTA MARIA DELLA SPERANZA U.O.C. Medicina Interna, Battipaglia, Salerno, Italy
🇮🇹
OSPEDALE MARIA S.S. DELLO SPLENDORE U.O.S.D. Allergologia Territoriale presidio ospedaliero Giulianova, Giulianova, Teramo, Italy

and more 25 locations

A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerging Adults

Not Applicable

Not yet recruiting

Conditions: Alcohol Use Disorder

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT07214831

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease

Not Applicable

Not yet recruiting

Conditions: Parkinsons Disease (PD)
Constipation - Functional

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Hospital de Clinicas de Porto Alegre

Target Recruit Count: 54

Registration Number: NCT07213856

Locations: 🇧🇷
Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil

Gastric POCUS Clear Liquids

Not Applicable

Completed

Conditions: Gastric Emptying Time

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: MetroHealth Medical Center

Target Recruit Count: 70

Registration Number: NCT07214909

Locations: 🇺🇸
MetroHealthMC, Cleveland, Ohio, United States

Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes

Not Applicable

Not yet recruiting

Conditions: Cannabis Intoxication

Interventions: Drug: Cannabis
Other: 0 mg THC (placebo)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 70

Registration Number: NCT07214155

Combined Circulatory and Dietary Interventions for Neuropathy

Not Applicable

Not yet recruiting

Conditions: Diabete Type 2
Neuropathy, Painful

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Loma Linda University

Target Recruit Count: 60

Registration Number: NCT07213843

Locations: 🇺🇸
Neuropathic Therapy Center, Loma Linda, California, United States

Relative Bioavailability of Evobrutinib Tablet Batches

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Treatment A
Drug: Treatment B
Drug: Treatment C
Drug: Treatment D

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Target Recruit Count: 28

Registration Number: NCT07214922

Locations: 🇩🇪
Nuvisan GmbH, Neu-Ulm, Germany

Treatment for /s/ Production Errors in Children With Speech Sound Errors

Not Applicable

Recruiting

Conditions: Speech Sound Disorder

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Syracuse University

Target Recruit Count: 24

Registration Number: NCT07214480

Locations: 🇺🇸
Syracuse University, Syracuse, New York, United States

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Not Applicable

Not yet recruiting

Conditions: Head and Neck Cancer
Recurrent Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Pembrolizumab
Radiation: Proton therapy

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Cincinnati

Target Recruit Count: 40

Registration Number: NCT07213934

Locations: 🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Enhanced Valves Interventions and Safe AI Generated End Results

Recruiting

Conditions: Heart Valve Disease
TAVI
M-TEER
TTVI
TMVI
T-TEER
Mitraclip
TriClip

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Montreal Heart Institute

Target Recruit Count: 21000

Registration Number: NCT07213531

Locations: 🇺🇸
Montefiore Medical Center New York, New York, New York, United States
🇨🇦
Montreal Heart Institute, 5000 Rue Bélanger, Montréal, Montreal, Quebec, Canada
🇨🇦
St Michael's Hospital Toronto, Toronto, Canada

and more 12 locations

AI-Powered Research

Premium Access

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab sc Injection in Italy

A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerging Adults

Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease

Gastric POCUS Clear Liquids

Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes

Combined Circulatory and Dietary Interventions for Neuropathy

Relative Bioavailability of Evobrutinib Tablet Batches

Treatment for /s/ Production Errors in Children With Speech Sound Errors

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Enhanced Valves Interventions and Safe AI Generated End Results

Product

Company

Legal